Skip to main content
Premium Trial:

Request an Annual Quote

TruDiagnostic Receives CLIA Certification for Kentucky Laboratory

NEW YORK – TruDiagnostic said on Monday that its Lexington, Kentucky-based laboratory has received CLIA certification in 49 states.

The CLIA certification includes advanced registration in California, Maryland, Rhode Island, and Pennsylvania. TruDiagnostic said in a statement that it expects to receive final registration in New York next month. A spokesperson for the company noted that New York's Clinical Laboratory Evaluation Program required additional information beyond the federal requirements for CLIA certification.

TruDiagnostic also said it launched a new dual-facing portal interface with a focus on epigenetics and reporting test interpretations. The portal allows patients and providers to view test results, track data, and receive personalized recommendations based on individual epigenetic data.

The health data company plans to launch the second phase of the portal in the third quarter of 2021, with new features such as multiple interfaces with healthcare providers' electronic medical records, connections with wearable devices for remote health monitoring, and enhanced web-based reporting. Patients will be able to receive personalized nutrition and fitness recommendations, while providers can view interventional recommendations.

TruDiagnostic was founded in 2020 and focuses on multiomics and epigenetics, with an epigenetic database of DNA methylation markers and covariates. Its TruAge test measures a patient's biological age by looking at DNA methylation, according to the company's website.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.